Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Malaysian Journal of Medical Sciences ; : 40-51, 2019.
Article in English | WPRIM | ID: wpr-756917

ABSTRACT

@#Introduction: Intracerebroventricular administration of streptozotocin (icv-STZ) induced apoptosis changes in neurons similar to Alzheimer's disease. The serotonergic system via its receptor involved in survival of neurons. The present study examined the ability of selective 5-HT1A receptor antagonist (NAD-299) and 5-HT2A receptor agonist (TCB-2) to attenuate the apoptosis caused by the icv-STZ in the rat. Methods: The icv-STZ (3 mg/kg, 10 μL, twice) induced neuronal loss in the hippocampus of adult male rats. Animals were divided into naive control, sham-operated, STZ+saline (1 μL, icv), STZ+NAD-299 (5 μg/μL, icv), STZ+TCB-2 (5 μg/μL, icv), and STZ+NAD-299+TCB-2 (5 μg/μL of any agent, icv) groups. Following the 35 days’ treatment period, neuronal apoptosis was detected using the Tunnel. Cells with morphological features of apoptotic cell were contended by microscopy. Results: TCB-2 and NAD-299 administration decreased number of apoptotic neurons in the treatment group compared with the STZ group. Combined treatment of STZ rat with NAD+TCB more decreased number of apoptotic cells in compare to TCB-2 or NAD-299 treated STZ groups. Conclusion: Treatment with 5-HT1A receptor antagonist or 5-HT2A receptor agonist diminished apoptosis. The beneficial effect of 5HT1A receptor inhibition was potentiated with activation of 5-HT2A receptor in prevention of apoptosis in hippocampus.

2.
Basic and Clinical Neuroscience. 2015; 6 (3): 147-154
in English | IMEMR | ID: emr-179395

ABSTRACT

Introduction: Previous studies have shown that cannabinoidergic system is involved in anxiety. However, there are controversial reports in the experimental studies. The aim of this study is to evaluate the effect of pharmacological stimulation or blocking of CB1 receptors and inhibition of endocannabinoid degradation in anxiety like behavior in elevated plus-maze [EPM] test in rat. The EPM is one of the most widely used animal models of anxiety


Methods: Male Wistar rats were randomly allocated to ten groups. Different groups of animals intraperitoneally received Win-55212 [0.3, 1 and 5 mg/kg] as CB1 receptor agonist, AM- 251 [0.3, 1 and 5 mg/kg] as CB1 receptor antagonist, URB-597 [0.03, 0.1 and 0.3 mg/kg] as endocannabinoid breakdown inhibitor or saline [as control group] 30 min before submitting into EPM test


Results: The results showed that compared to the control group, Win-55212 [1 and 5 mg/kg] and URB-597 [0.1 and 0.3 mg/kg] significantly increased both of the time and percentage of entries into open arms. AM-251 [1 and 5 mg/kg] significantly decreased the time and percentage of entries into open arms in the EPM test. These substances have no effects on the total distance covered by animals and number of closed arm entries


Discussion: It is concluded that activation of cannabinoid receptor exert anxiolytic effect while blocking of cannabinoid receptor resulted in anxiety behavior. The locomotor activity was not significantly changed by cannabinoid system. It is suggested that potentiation of cannabinoid system may be therapeutic strategy for the anxiety behavior

3.
Basic and Clinical Neuroscience. 2011; 2 (4): 27-35
in English | IMEMR | ID: emr-191862

ABSTRACT

Introduction: The role of serotonergic fibers in avoidance learning is controversial. Involvement of the dorsal raphe nucleus [DRN], the main source of hippocampal projecting serotonergic fibers in acquisition, consolidation and retrieval of passive avoidance [PA] learning, was investigated by functional suppression of this area. Materials and Methods: DRN functional inactivation was done by lidocaine [0.5µl, 2%] injection into the DRN, 5 min before training [n=10]; and 5 [n=9], 90 [n=10] and 360 min [n=9] after acquisition trial. In the last experiment, lidocaine was injected into the DRN 5 min before the retrieval test, which was 48 h after the training [n=10]. Results: Our results showed that PA learning was not impaired by DRN inactivation 5 min before training nor 5 and 360 min after training. Lidocaine injected 90 min after the acquisition trial significantly reduced avoidance of the dark compartment [P<0.001]. Intra-DRN injection of lidocaine before retrieval significantly increased PA retention [P<0.001]. Therefore, it seems that DRN has opposite effects on consolidation and retrieval of passive avoidance learning, but it has no effect on PA acquisition. Discussion: It is suggested that functional ablation of DRN may disrupt integrity of subcortical circuits participating in PA consolidation, but DRN inactivation by increasing brain awareness may affect PA retrieval in rats

4.
IBJ-Iranian Biomedical Journal. 2008; 12 (4): 237-240
in English | IMEMR | ID: emr-86692

ABSTRACT

The nucleus raphe magnus [NRM] is involved in thermoregulatory processing. There is a correlation between changes in the firing rates of the cells in the NRM and the application of the peripheral thermal stimulus. We examined the effect of reversible inactivation and excitation of NRM on mechanisms involved in tail blood flow [TBF] regulation in hypothermia. Hypothermia was induced in Male Wistar rats and cannula was implanted above the NRM. To evaluate the effect of nucleus inactivation on TBF, the amount of TBF was measured by Laser Doppler in hypothermic rats, before and after lidocaine microinjection into NRM. TBF was also measured after glutamate microinjection to assess the effect of nucleus excitation in hypothermic rats. Results indicated that after dropping TBF by hypothermia, microinjection of lidocaine into NRM significantly decreased TBF from 54.43 +/- 5.7 to 46.81 +/- 3.4, whereas glutamate microinjection caused a significant increase from 44.194 +/- 0.6 to 98 +/- 10.0 Conclusion: These data suggest that NRM have thermoregulatory effect in response to hypothermia


Subject(s)
Male , Animals, Laboratory , Hypothermia , Rats, Wistar , Tail/blood supply , Lidocaine , Glutamic Acid , Laser-Doppler Flowmetry
SELECTION OF CITATIONS
SEARCH DETAIL